Works matching IS 02704137 AND DT 2024 AND VI 84 AND IP 6

Results: 10

A novel HDAC6 inhibitor interferes microtubule dynamics and spindle assembly checkpoint and sensitizes cisplatin‐induced apoptosis in castration‐resistant prostate cancer.

Published in:

Prostate, 2024, v. 84, n. 6, p. 605, doi. 10.1002/pros.24678

By:

Ye, Pei‐Chen;
Leu, Wohn‐Jenn;
Yeh, Tsung‐Yu;
Hsu, Yu‐Tung;
Lin, Yi‐Chin;
Wei, Zi‐Yuan;
Chen, Yi‐Chin;
Chiang, Yi‐Chang;
Hsu, Jui‐Ling;
Chan, She‐Hung;
Hsu, Lih‐Ching;
Chern, Ji‐Wang;
Yu, Chao‐Wu;
Guh, Jih‐Hwa

Publication type:

Article

Nonantibiotic strategies to decrease the postbiopsy hospitalization rates because of infectious complications after transrectal prostate biopsy.

Published in:

Prostate, 2024, v. 84, n. 6, p. 599, doi. 10.1002/pros.24677

By:

Bostancı, Coşkun

Publication type:

Article

Development of depression in patients using androgen deprivation therapy: A systemic review and meta‐analysis.

Published in:

Prostate, 2024, v. 84, n. 6, p. 525, doi. 10.1002/pros.24676

By:

Qazi, Shurjeel Uddin;
Altaf, Zahabia;
Zafar, Mariam;
Tariq, Muhammad Ali;
Khalid, Areesha;
Kaleem, Aleesha;
Saad, Emaan;
Qazi, Sana

Publication type:

Article

Prostate and gut: Any relationship? A narrative review on the available evidence and putative mechanisms.

Published in:

Prostate, 2024, v. 84, n. 6, p. 513, doi. 10.1002/pros.24675

By:

Romano, Lorenzo;
Napolitano, Luigi;
Crocetto, Felice;
Sciorio, Carmine;
Sio, Marco De;
Miranda, Agnese;
Romano, Marco;
Priadko, Kateryna

Publication type:

Article

Efficacy, tolerability, and safety of teverelix DP in patients with advanced prostate cancer: A multicenter, open‐label, phase 2 trial.

Published in:

Prostate, 2024, v. 84, n. 6, p. 584, doi. 10.1002/pros.24674

By:

Ulys, Albertas;
Jankevicus, Feliksas;
Jievaltas, Mindaugas;
Venckus, Raimundas;
Auskalnis, Stasys;
Kardelis, Zygimantas;
Barisiene, Marija;
MacLean, Carol M.;
van Os, Steve;
Larsen, Finn

Publication type:

Article

Estimating disparities of prostate cancer burden and its attributable risk factors for males across the BRICS‐plus, 1990–2019: A comparable study of key nations with emerging economies.

Published in:

Prostate, 2024, v. 84, n. 6, p. 570, doi. 10.1002/pros.24673

By:

Luo, Li‐Sha;
Huang, Jiao;
Luan, Hang‐Hang;
Mubarik, Sumaira;
Zhong, Quliang;
Zeng, Xian‐Tao

Publication type:

Article

Impact of presentation timing in metastatic hormone‐sensitive prostate cancer: Characterization of patients and identification of prognostic factors.

Published in:

Prostate, 2024, v. 84, n. 6, p. 560, doi. 10.1002/pros.24672

By:

Hoyos, Juliana Arenas;
Londoño, David Ruiz;
Hoyos, Andres Gomez;
Reyes, Estefania Celis;
Varela, Rodolfo;
Giraldo, Julian Serrano

Publication type:

Article

Metabolic analysis using HR‐MAS in prostate tissue for prostate cancer diagnosis.

Published in:

Prostate, 2024, v. 84, n. 6, p. 549, doi. 10.1002/pros.24670

By:

Panach‐Navarrete, Jorge;
González‐Marrachelli, Vannina;
Morales‐Tatay, José Manuel;
García‐Morata, Francisco;
Sales‐Maicas, María Ángeles;
Monleón‐Salvado, Daniel;
Martínez‐Jabaloyas, José María

Publication type:

Article

Utilization trend of prebiopsy multiparametric magnetic resonance imaging and its impact on prostate cancer detection: Real‐world insights from a high‐volume center in southwest China.

Published in:

Prostate, 2024, v. 84, n. 6, p. 539, doi. 10.1002/pros.24669

By:

Zhang, Chichen;
Tu, Xiang;
Dai, Jindong;
Zhang, Zilong;
Shen, Chenlan;
Wu, Qiyou;
Liu, Zhenhua;
Lin, Tianhai;
Qiu, Shi;
Yang, Lu;
Yang, Ling;
Zhang, Mengni;
Cai, Diming;
Bao, Yige;
Zeng, Hao;
Wei, Qiang

Publication type:

Article

Issue Information.

Published in:: Prostate, 2024, v. 84, n. 6, p. 511, doi. 10.1002/pros.24566
Publication type:: Article